214 related articles for article (PubMed ID: 33909135)
21. Sleeve lobectomy for non-small cell lung cancer with N1 nodal disease does not compromise survival.
Berry MF; Worni M; Wang X; Harpole DH; D'Amico TA; Onaitis MW
Ann Thorac Surg; 2014 Jan; 97(1):230-5. PubMed ID: 24206972
[TBL] [Abstract][Full Text] [Related]
22. Longitudinal Follow-up of Lung Cancer Resection From the Society of Thoracic Surgeons General Thoracic Surgery Database in Patients 65 Years and Older.
Fernandez FG; Furnary AP; Kosinski AS; Onaitis MW; Kim S; Boffa D; Cowper P; Jacobs JP; Wright CD; Putnam JB
Ann Thorac Surg; 2016 Jun; 101(6):2067-76. PubMed ID: 27157052
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors in neoadjuvant treatment followed by surgery in stage IIIA-N2 non-small cell lung cancer: a multi-institutional study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society).
Couñago F; Montemuiño S; Martin M; Taboada B; Calvo-Crespo P; Samper-Ots MP; Alcántara P; Corona J; López-Guerra JL; Murcia-Mejía M; López-Mata M; Jové-Teixidó J; Chust M; Díaz-Díaz V; de Ingunza-Barón L; García-Cañibano T; Couselo ML; Del Cerro E; Moradiellos J; Amor S; Varela A; Puertas MM; Thuissard IJ; Sanz-Rosa D; de Dios NR
Clin Transl Oncol; 2019 Jun; 21(6):735-744. PubMed ID: 30430394
[TBL] [Abstract][Full Text] [Related]
24. Morbidity and mortality of lobectomy or pneumonectomy after neoadjuvant treatment: an analysis from the ESTS database.
Brunelli A; Rocco G; Szanto Z; Thomas P; Falcoz PE
Eur J Cardiothorac Surg; 2020 Apr; 57(4):740-746. PubMed ID: 31638692
[TBL] [Abstract][Full Text] [Related]
25. A nomogram to predict the survival of stage IIIA-N2 non-small cell lung cancer after surgery.
Mao Q; Xia W; Dong G; Chen S; Wang A; Jin G; Jiang F; Xu L
J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1784-1792.e3. PubMed ID: 29554790
[TBL] [Abstract][Full Text] [Related]
26. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
van Meerbeeck JP; Kramer GW; Van Schil PE; Legrand C; Smit EF; Schramel F; Tjan-Heijnen VC; Biesma B; Debruyne C; van Zandwijk N; Splinter TA; Giaccone G;
J Natl Cancer Inst; 2007 Mar; 99(6):442-50. PubMed ID: 17374834
[TBL] [Abstract][Full Text] [Related]
27. Comparison of surgical results after pneumonectomy and sleeve lobectomy for non-small cell lung cancer: trends over time and 20-year institutional experience.
Takeda S; Maeda H; Koma M; Matsubara Y; Sawabata N; Inoue M; Tokunaga T; Ohta M
Eur J Cardiothorac Surg; 2006 Mar; 29(3):276-80. PubMed ID: 16434204
[TBL] [Abstract][Full Text] [Related]
28. Prediction of Long-Term Survival After Lung Cancer Surgery for Elderly Patients in The Society of Thoracic Surgeons General Thoracic Surgery Database.
Onaitis MW; Furnary AP; Kosinski AS; Kim S; Boffa D; Tong BC; Cowper P; Jacobs JP; Wright CD; Putnam JB; Fernandez FG
Ann Thorac Surg; 2018 Jan; 105(1):309-316. PubMed ID: 29174391
[TBL] [Abstract][Full Text] [Related]
29. The long-term survival of robotic lobectomy for non-small cell lung cancer: A multi-institutional study.
Cerfolio RJ; Ghanim AF; Dylewski M; Veronesi G; Spaggiari L; Park BJ
J Thorac Cardiovasc Surg; 2018 Feb; 155(2):778-786. PubMed ID: 29031947
[TBL] [Abstract][Full Text] [Related]
30. Surgical therapeutic strategy for non-small cell lung cancer with mediastinal lymph node metastasis (N2).
Ma Q; Liu D; Guo Y; Shi B; Song Z; Tian Y
Zhongguo Fei Ai Za Zhi; 2010 Apr; 13(4):342-8. PubMed ID: 20677562
[TBL] [Abstract][Full Text] [Related]
31. Management of stage IIIA non-small cell lung cancer by thoracic surgeons in North America.
Veeramachaneni NK; Feins RH; Stephenson BJ; Edwards LJ; Fernandez FG
Ann Thorac Surg; 2012 Sep; 94(3):922-6; discussion 926-8. PubMed ID: 22742842
[TBL] [Abstract][Full Text] [Related]
32. Invasive Mediastinal Staging for Lung Cancer by The Society of Thoracic Surgeons Database Participants.
Krantz SB; Howington JA; Wood DE; Kim KW; Kosinski AS; Cox ML; Kim S; Mulligan MS; Farjah F
Ann Thorac Surg; 2018 Oct; 106(4):1055-1062. PubMed ID: 29883646
[TBL] [Abstract][Full Text] [Related]
33. Lobectomy does not confer survival advantage over segmentectomy for non-small cell lung cancer with unsuspected nodal disease.
Razi SS; Nguyen D; Villamizar N
J Thorac Cardiovasc Surg; 2020 Jun; 159(6):2469-2483.e4. PubMed ID: 31928821
[TBL] [Abstract][Full Text] [Related]
34. Outcomes of neoadjuvant concurrent chemoradiotherapy followed by surgery for non-small-cell lung cancer with N2 disease.
Kim HK; Cho JH; Choi YS; Zo JI; Shim YM; Park K; Ahn MJ; Ahn YC; Kim K; Kim J
Lung Cancer; 2016 Jun; 96():56-62. PubMed ID: 27133751
[TBL] [Abstract][Full Text] [Related]
35. Anatomical segmentectomy versus pulmonary lobectomy for stage I non-small-cell lung cancer: patients selection and outcomes from the European Society of Thoracic Surgeons database analysis.
Tosi D; Nosotti M; Bonitta G; Mendogni P; Bertolaccini L; Spaggiari L; Brunelli A; Ruffini E; Falcoz PE
Interact Cardiovasc Thorac Surg; 2021 Apr; 32(4):546-551. PubMed ID: 33313840
[TBL] [Abstract][Full Text] [Related]
36. Surgical Results of Non-small Cell Lung Cancer in Nepal.
Thakur B; Yonghui D; Devkota M; Poudel B; Baral P
JNMA J Nepal Med Assoc; 2014; 52(196):992-6. PubMed ID: 26982898
[TBL] [Abstract][Full Text] [Related]
37. Complete thoracic mediastinal lymphadenectomy leads to a higher rate of pathologically proven N2 disease in patients with non-small cell lung cancer.
Cerfolio RJ; Bryant AS; Minnich DJ
Ann Thorac Surg; 2012 Sep; 94(3):902-6. PubMed ID: 22776083
[TBL] [Abstract][Full Text] [Related]
38. Survival following lobectomy and limited resection for the treatment of stage I non-small cell lung cancer<=1 cm in size: a review of SEER data.
Kates M; Swanson S; Wisnivesky JP
Chest; 2011 Mar; 139(3):491-496. PubMed ID: 20576736
[TBL] [Abstract][Full Text] [Related]
39. Neoadjuvant treatment followed by surgery versus definitive chemoradiation in stage IIIA-N2 non-small-cell lung cancer: A multi-institutional study by the oncologic group for the study of lung cancer (Spanish Radiation Oncology Society).
Couñago F; Rodriguez de Dios N; Montemuiño S; Jové-Teixidó J; Martin M; Calvo-Crespo P; López-Mata M; Samper-Ots MP; López-Guerra JL; García-Cañibano T; Díaz-Díaz V; de Ingunza-Barón L; Murcia-Mejía M; Alcántara P; Corona J; Puertas MM; Chust M; Couselo ML; Del Cerro E; Moradiellos J; Amor S; Varela A; Thuissard IJ; Sanz-Rosa D; Taboada B
Lung Cancer; 2018 Apr; 118():119-127. PubMed ID: 29571989
[TBL] [Abstract][Full Text] [Related]
40. Morbidity and mortality after major pulmonary resections in patients with locally advanced stage IIIA non-small cell lung carcinoma who underwent induction therapy.
Peer M; Stav D; Cyjon A; Sandbank J; Vasserman M; Haitov Z; Sasson L; Schreiber L; Ezri T; Priel IE; Hayat H
Heart Lung Circ; 2015 Jan; 24(1):69-76. PubMed ID: 25086910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
